Skip to content

Drug interactions

Buprenorphine transdermal + Sorafenib

Severity: Moderate

Buprenorphine transdermal and Sorafenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sorafenib and buprenorphine can each prolong the QT interval. Used together they may add to the risk of torsades de pointes, particularly in patients with electrolyte disturbances or structural heart disease.

What this interaction means in plain words

Buprenorphine transdermal and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Obtain a baseline ECG and correct potassium and magnesium before combining. Repeat ECGs periodically, and consider another analgesic if the QTc rises markedly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine transdermal and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine transdermal with Sorafenib?

MediHelp rates the interaction as moderate. Buprenorphine transdermal and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sorafenib and buprenorphine can each prolong the QT interval. Used together they may add to the risk of torsades de pointes, particularly in patients with electrolyte disturbances or structural heart disease.

How serious is the interaction between Buprenorphine transdermal and Sorafenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium before combining. Repeat ECGs periodically, and consider another analgesic if the QTc rises markedly.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in